Population Pharmacokinetics and Prediction of Dopamine D2 Receptor Occupancy After Multiple Doses of RBP‐7000, a New Sustained‐Release Formulation of Risperidone, in Schizophrenia Patients on Stable…

Overview of attention for article published in Clinical Pharmacokinetics, January 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

policy: 1 policy source
twitter: 1 X user

patent: 11 patents

Citations

dimensions_citation: 25 Dimensions

Readers on

mendeley: 40 Mendeley

Summary Policy documents X Patents Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

risperidone

Cited by Canadian Agency for Drugs and Technologies in Health on 08 Nov 2021

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.